Milan Laboratories (India) Private Limited

Milan Laboratories (India) Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2003PTC139736 Incorporated 26 March 2003 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹429.23 Cr
▲ 42% YoY
Net profit · FY 2024
₹52.95 Cr
Net margin 12.3%
EBITDA · FY 2024
₹105.17 Cr
EBITDA margin 24.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.98 Cr
Issued & subscribed
Open charges
₹70.39 Cr
Satisfied ₹79.75 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
628
Provident fund records

About Milan Laboratories (India) Private Limited

Data last updated:

Milan Laboratories (India) Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC139736. Its GSTIN is 27AADCM5148B1ZQ (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.98 Cr. It is led by directors including Upendra Madan Despande and Rohini Rajeev Dongre.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 303/304 3rd Floor Odyssey IT Park Wagle Estate MIDC Thane(W), Maharashtra, India – 400604.

As per the financials filed for FY 2024, the company reported a revenue of ₹429.23 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹52.95 Cr (net margin 12.3%) and EBITDA of ₹105.17 Cr (EBITDA margin 24.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 20% over five years.

The company has about 628 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Milan Laboratories. As per MCA filings, the company has open charges of ₹70.39 Cr and satisfied charges of ₹79.75 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2018. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Medispray Laboratories Private Limited with revenue of ₹444.46 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2024, listing 1,021 overdue payments to 97 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website milanlabs.com.

Company details

CIN U24230MH2003PTC139736
Registration Number 139736
Incorporation Date 26 March 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

Contact details

Milan Laboratories (India) Private Limited's registered office is in Thane, Maharashtra. Its website is milanlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    303/304 3rd Floor Odyssey IT Park Wagle Estate MIDC Thane(W), Maharashtra, India – 400604
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Milan Laboratories (India) Private Limited, buy the company report.

Comprehensive company report
Milan Laboratories (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Milan Laboratories (India) operates one associated brand: Milan Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and exporting with WHO-cGMP compliance.milanlabs.com

Business activity

The main business activity of Milan Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Milan Laboratories (India) Private Limited, buy the company report.

Financials of Milan Laboratories (India) Private Limited

FY 2024 filings available

Milan Laboratories (India) Private Limited reported revenue of ₹429.23 Cr (up 42% YoY) for FY 2024.

Revenue · FY 2024
₹429.23 Cr ▲ 42%
Net profit · FY 2024
₹52.95 Cr margin 12.3%
EBITDA · FY 2024
₹105.17 Cr margin 24.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 15%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 10%
5 years · compounded
▲ 31%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 42% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹429.23 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹105.17 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹52.95 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin24.5%
Net Profit Margin12.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Milan Laboratories (India) Private Limited, buy the company report.

Board of directors of Milan Laboratories (India) Private Limited

Milan Laboratories (India) has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Upendra Madan DespandeDirector26 Mar 200323 Years 7 MonthsCurrent
Rohini Rajeev DongreDirector26 Mar 200323 Years 7 MonthsCurrent
Sharwari Upendra DeshpandeDirector13 Mar 20251 Years 7 MonthsCurrent
Rahul Rajeev DongreDirector23 May 20251 Years 5 MonthsCurrent

Peer comparison

Milan Laboratories (India) Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medispray Laboratories Private Limited₹444.46 Cr (FY 2025)7.0%Goa, India
Copmed Pharmaceuticals Private Limited₹437.53 Cr (FY 2025)-5.0%New Delhi, Delhi, India
Hazelo Lab Private Limited₹431.64 Cr (FY 2024)3.0%Chityal, Telangana, India
Zydus Hospira Oncology Private Limited₹430.96 Cr (FY 2025)66.0%Village Matoda Tal Sanand, Gujarat, India
Halewood Laboratories Private Limited₹430.29 Cr (FY 2025)20.0%Ahmedabad, Gujarat, India
Milan Laboratories (India) Private Limitedthis company₹429.23 Cr (FY 2024)₹52.95 Cr12.3%42.0%576Thane, Maharashtra, India
Escientia Advanced Sciences Private Limited₹423.15 Cr (FY 2024)114.0%Shameerpet, Telangana, India
Recipharm Pharmaservices Private Limited₹421.11 Cr (FY 2025)-3.0%Mumbai, Maharashtra, India
Albert David Ltd₹420.01 Cr (FY 2024)18.0%Kolkata, West Bengal, India
Aspiro Pharma Limited₹418.29 Cr (FY 2025)147.0%Markook, Telangana, India

To see the full peer comparison of Milan Laboratories (India) Private Limited, buy the company report.

Auditor

Milan Laboratories (India) Private Limited is audited by R. P. SHAH & CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R. P. SHAH & CO.FY 2024109759W

Shareholding

The shareholding of Milan Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Milan Laboratories (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹70.39 Cr
Satisfied charges
₹79.75 Cr
Breakdown by lending institutions
Others₹52.20 Cr
Standard Chartered Bank₹16.00 Cr
Dbs Bank Ltd₹1.65 Cr
Tata Capital Financial Services Limited₹0.54 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jan 2024100884144Standard Chartered Bank₹10 CrOpen
11 Apr 2022100567445Others₹20 CrOpen
02 Jan 2021100417839Standard Chartered Bank₹1 CrOpen
02 Jan 2021100417841Standard Chartered Bank₹5 CrOpen
18 Sep 2019100292828Others₹12.2 CrOpen

To see the full charge records of Milan Laboratories (India) Private Limited, buy the company report.

Total charge records: 20 View all charges

Deals & funding

Milan Laboratories (India) Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2018.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2018Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Milan Laboratories (India) Private Limited has 7 MSME Form 1 returns on record between 2019 and 2024, listing 1,021 overdue payments to 97 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 97)

SupplierAmount dueDue sinceReported on
Eneffen Technologies Private Limited
an individual supplier
Hightech Industries
an individual supplier
Innovative Print Pack Private Limited

To see the full MSME payment records of Milan Laboratories (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Milan Laboratories (India) has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Oriental Grills Pvt LtdU28111MH1987PTC045449

To see the full group structure of Milan Laboratories (India) Private Limited, buy the company report.

Employees & EPFO

Milan Laboratories (India) Private Limited has a workforce of 576 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.

Employee count
576
Active EPFO establishments
1
Employee growth
17.07%

GST

Milan Laboratories (India) has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AADCM5148B1ZQMaharashtraActive01 Jul 2017
24AADCM5148B1ZWGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Milan Laboratories (India) Private Limited, buy the company report.

Recent activity

Milan Laboratories (India) Private Limited has 6 board changes on record since 2003: 4 appointments and 2 cessations. The latest: Rahul Rajeev Dongre ceased to be Additional Director on 29 Sep 2025.

Ceased
Rahul Rajeev Dongre ceased to be Additional Director.
Charges
A charge registered on 01 Apr 2011 via Charge ID 10285507 with Tata Capital Limited was fully satisfied on 08 Sep 2025.
Appointed
Rahul Rajeev Dongre was appointed as Director.
Appointed
Sharwari Upendra Deshpande was appointed as Director.
Ceased
Upendra Madan Despande ceased to be Director.
Charges
A charge registered on 25 Jan 2022 via Charge ID 100542691 with Others was fully satisfied on 17 Feb 2025.
Charges
A charge registered on 08 Sep 2021 via Charge ID 100478192 with Standard Chartered Bank was fully satisfied on 17 Feb 2025.
AGM
Milan Laboratories (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Milan Laboratories (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Standard Chartered Bank amounted to Rs. 10.00 Cr with Charge ID 100884144 was registered on 31 Jan 2024.
Charges
A charge with Others of Rs. 20.00 Cr registered on 11 Apr 2022 with Charge ID 100567445 was modified on 31 Jan 2024.
Charges
A charge with Standard Chartered Bank of Rs. 30.75 Cr registered on 08 Sep 2021 with Charge ID 100478192 was modified on 31 Jan 2024.

36 earlier events are in the company report.

Frequently asked questions

Milan Laboratories (India) is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2003 (23+ years old) and is registered under CIN U24230MH2003PTC139736.

Milan Laboratories (India) has 4 current directors:

The latest financial statements of Milan Laboratories (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Milan Laboratories (India) is 27AADCM5148B1ZQ, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AADCM5148B1ZW (Gujarat).

The CIN (Corporate Identification Number) of Milan Laboratories (India) is U24230MH2003PTC139736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Milan Laboratories (India) has 4 court cases on record: 2 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.

Milan Laboratories (India) was incorporated on 26 March 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.

Milan Laboratories (India) has 1 deal on record (1 secondary share transfer); the latest was in March 2018.

The peers of Milan Laboratories (India) by revenue are Medispray Laboratories Private Limited, Copmed Pharmaceuticals Private Limited, Hazelo Lab Private Limited, Zydus Hospira Oncology Private Limited, Halewood Laboratories Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rahul Rajeev Dongre ceased to be Additional Director on 29 Sep 2025. Rahul Rajeev Dongre was appointed as Director on 23 May 2025. Sharwari Upendra Deshpande was appointed as Director on 13 Mar 2025. Milan Laboratories (India) has 6 board changes on record in total.

Milan Laboratories (India) has 7 MSME Form 1 returns on record between 2019 and 2024, listing 1,021 overdue payments to 97 micro and small suppliers. The latest return was filed on 23 Apr 2024.

Milan Laboratories (India) can be reached through the website milanlabs.com. Its registered office is in Thane, Maharashtra, India.